Content about Basal cell carcinoma

January 30, 2012
FDA approves Genentech skin cancer drug

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

September 8, 2010
Perrigo gets approval for generic Aldara

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

March 7, 2010
Taro receives FDA approval for skin cancer generic

The Food and Drug Administration has approved Taro Pharmaceutical Industries’ generic version of a drug...

February 25, 2010
Fougera receives FDA approval for generic Aldara

The Food and Drug Administration has given E. Fougera & Co. approval for the first...

January 5, 2010
Study: NSAID may reduce skin cancer

A new study found that a nonsteroidal anti-inflammatory drug may reduce a patient's risk of...

© 2012 Drug Store News. All Rights Reserved.